Related Experiment Video
Updated: May 11, 2026
Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
Identification of histone deacetylase 1 protein complexes in liver cancer cells
Muhammad Farooq1, Wael N Hozzein, Elsayed A Elsayed
1Bioproducts Research Group, Department of Zoology, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia. fmuhammad@ksu.edu.sa
Background:
Hepatocellular carcinoma is one of the leading causes of mortalities worldwide. The search for new therapeutic targets is of utmost importance for improved treatment. Altered expression of HDAC1 in hepatocellular carcinoma (HCC) and its requirement for liver formation in zebrafish, suggest that it may regulate key events in liver carcinogenesis and organogenesis. However, molecular mechanisms of HDAC1 action in liver carcinogenesis are largely unknown. The present study was conducted to identify HDAC1 interacting proteins in HepG2 cells using modified SH-double-affinity purification coupled with liquid mass spectrophotemetery.
Materials And Methods:
HepG2 cells were transfected with a construct containing HDAC1 with a C-terminal strepIII-HA tag as bait. Bait proteins were confirmed to be expressed in HepG2 cells by western blotting and purified by double affinity columns and protein complexes for analysis on a Thermo LTQ Orbitrap XL using a C18 nano flow ESI liquid chromatography system.
Results:
There were 27 proteins which showed novel interactions with HDAC1 identified only in this study, while 14 were among the established interactors. Various subunits of T complex proteins (TCP1) and prefoldin proteins (PFDN) were identified as interacting partners that showed high affinity with HDAC1 in HepG2 cells.
Conclusions:
The double affinity purification method adopted in this study was very successful in terms of specificity and reproducibility. The novel HDAC1 complex identified in this study could be better therapeutic target for treatment of hepatocellular carcinoma.
Insights
Researchers identified novel proteins interacting with HDAC1 in liver cancer cells. This discovery of new HDAC1 complexes offers potential therapeutic targets for hepatocellular carcinoma (HCC) treatment.
Area of Science:
- Molecular biology
- Cancer research
- Proteomics
Background:
- Hepatocellular carcinoma (HCC) is a major global health concern with limited treatment options.
- Histone deacetylase 1 (HDAC1) is implicated in liver carcinogenesis, but its molecular mechanisms remain unclear.
- Understanding HDAC1's interactions is crucial for identifying new therapeutic strategies.
Purpose of the Study:
- To identify novel HDAC1-interacting proteins in HepG2 cells.
- To elucidate the molecular mechanisms of HDAC1 in liver cancer.
- To discover potential therapeutic targets for HCC.
Main Methods:
- Utilized modified SH-double-affinity purification coupled with liquid mass spectrometry.
- Transfected HepG2 cells with tagged HDAC1 as bait.
- Confirmed protein expression and purified complexes using advanced chromatography and mass spectrometry.
Main Results:
- Identified 27 novel HDAC1 interacting proteins and 14 known interactors.
- Discovered high-affinity interactions between HDAC1 and subunits of T complex proteins (TCP1) and prefoldin proteins (PFDN).
- Demonstrated the specificity and reproducibility of the double affinity purification method.
Conclusions:
- The double affinity purification method is effective for identifying protein complexes.
- Novel HDAC1 complexes, including TCP1 and PFDN, represent promising therapeutic targets for HCC.
- Further research into these interactions could lead to improved HCC treatments.
